These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The treatment effect of ribavirin to hemorrhagic fever with renal syndrome on the kinetics of serum creatine phosphate kinase isoenzyme].
    Author: Zhang Q, Tang R, Yuan G.
    Journal: Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep 30; 13(3):266-8. PubMed ID: 12569761.
    Abstract:
    OBJECTIVE: To study the effect of ribavirin treatment on kinetics of serum creatine phosphate kinase isoenzyme(CK-MB) of patients with hemoarrhagic fever with renal syndrome(HFRS). METHODS: CK-MB levels in 155 HFRS patients treated with larger dose of ribavirin and with routine therapeutic dose were observed dynamicaly, using randomly controlled double-blind method. In addition, CK-MB levels in different disease phases and different clinical types of HFRS were compared. RESULTS: The results showed that CK-MB levels were significantly increased in febrile phase and decreased gradually to normal during convalescent phase in both groups, but in febrile phase, CK-MB levels in ribavirin-treated group and control group were 55.25 +/- 18.25 IU/L and 69.63 +/- 23.52 IU/L, respectively, the treated group had a lower level (P < 0.05). The severe and critical group treated by ribavirin showed a lower CK-MB level of 47.74 +/- 24.82 IU/L, while the control group showed a higher level of 66.08 +/- 25.01 IU/L(P < 0.05). CONCLUSION: These results indicated that an early application of large dose of ribavirin in treatment of HFRS can reduce the serum CK-MB levels in patients with HFRS.
    [Abstract] [Full Text] [Related] [New Search]